PanK1α and PPAR-α expression in response to LPS over time. a, upper, primary BMDM were stimulated with LPS (100 ng/ml) for the times indicated. Expression of PanK1α was measured by RT-PCR. Results were normalized to the endogenous control GAPDH and are represented as -fold stimulation over the nonstimulated control. R.E., relative expression. Lower, primary BMDM were stimulated with LPS (100 ng/ml) for the times indicated and assessed for PanK1α and β-actin. Relative intensity (R.I.) is shown to compare intensity of the Western blot bands relative to time 0. b, upper, WT I-BMDM, MyD88-deficient I-BMDM, and Trif-deficient I-BMDM were stimulated with LPS (100 ng/ml) for 8 or 24 h. Lower, WT MEF or p65-deficient MEF were stimulated with LPS (100 ng/ml) for the times indicated. c, upper, primary BMDM were stimulated with LPS (100 ng/ml) for the times indicated. Expression of PPAR-α was measured by RT-PCR in the same manner as PanK1α. Lower, primary BMDM were stimulated with LPS (100 ng/ml) for the times indicated and assessed for PPAR-α and β-actin. Relative intensity is shown below. d, upper, WT I-BMDM, MyD88-deficient I-BMDM, and Trif-deficient I-BMDM were stimulated with LPS (100 ng/ml) for 8 or 24 h. Lower, WT MEF or p65-deficient MEF were stimulated with LPS (100 ng/ml) for the times indicated. e, I-BMDM were pretreated with 10 μm WY14643 for 30 min before the addition of LPS (100 ng/ml) for 24 h. Expression of miR-107, PanK1α, and PPAR-α was measured by RT-PCR. Results were normalized to the endogenous controls RNU6b (miR-107) or GAPDH (PanK1α and PPAR-α) and are represented as -fold stimulation over the dimethyl sulfoxide (DMSO) control. f, ELISA of mouse TNF-α was measured in supernatants of samples pretreated with WY14643 before LPS stimulation. In all cases, results are expressed as mean ± S.E. (error bars) of triplicate determinations from three separate experiments. *, p < 0.05;**, p < 0.01.